Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Evoke Pharma Q1 EPS $(0.51) Misses $(0.33) Estimate, Sales $3.08M Miss $3.32M Estimate

Author: Benzinga Newsdesk | May 13, 2025 03:35pm
Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.51) per share which missed the analyst consensus estimate of $(0.33) by 54.55 percent. This is a 75.6 percent increase over losses of $(2.09) per share from the same period last year. The company reported quarterly sales of $3.08 million which missed the analyst consensus estimate of $3.32 million by 7.12 percent. This is a 77.52 percent increase over sales of $1.74 million the same period last year.

Posted In: EVOK


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist